Treatment of equine degenerative joint disease with autologous peripheral blood-derived mesenchymal stem cells: a case reportReport as inadecuate




Treatment of equine degenerative joint disease with autologous peripheral blood-derived mesenchymal stem cells: a case report - Download this document for free, or read online. Document in PDF available to download.

(2012)VLAAMS DIERGENEESKUNDIG TIJDSCHRIFT.81(1).p.11-15 Mark abstract A 5-year-old German Warmblood stallion with chronic lameness, attributable to degenerative joint disease (DJD) of the pastern joint unresponsive to medical treatments, was treated with autologous mesenchymal stem cells (MSC). These MSC were isolated from the peripheral blood (PB) of the patient and injected into the pastern joint, at a concentration of 2.5x10(6) cells, twice with an 8-week interval. The positive response to this stem cell treatment was documented by visual gait evaluation as well as objective pressure plate analyses. This paper is the first to describe the use of autologous PB-derived MSC to treat a horse suffering from chronic DJD. The favorable outcome of this single case may stimulate further research on the use of equine peripheral blood as a source of autologous MSC in equine regenerative medicine.

Please use this url to cite or link to this publication: http://hdl.handle.net/1854/LU-2082164



Author: Jan Spaas, Maarten Oosterlinck , Sarah Broeckx , Michèle Dumoulin , Jimmy Saunders , Ann Van Soom , Frederik Pille and Gerlinde V

Source: https://biblio.ugent.be/publication/2082164



DOWNLOAD PDF




Related documents